CliffBio
small molecule

FML FORTE

FLUOROMETHOLONE

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameFML FORTE
Active ingredientFLUOROMETHOLONE
Strength0.25%
Dosage formSUSPENSION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalApril 1986
Marketing statusRX

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

FML FORTE patent cliff — loss of exclusivity — | CliffBio